TickerFacts.

BGM Group Ltd. (BGM): Operating Income

Annual figures by period end, from SEC filings.

-$12.58M
Year ended 2025-09-30
$6.18M2018-09-30: $5.97M2019-09-30: $6.18M2020-09-30: $4.81M2021-09-30: $2.39M2022-09-30: $2.10M2023-09-30: -$2.61M2024-09-30: -$563.8K2025-09-30: -$12.58M-$12.58M
2018-09-30 Operating Income (USD) 2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30-$12.58Mn/m2026-07-21, From 2024-10-01
2024-09-30-$563.8Kn/m2026-07-21, From 2023-10-01
2023-09-30-$2.61Mn/m2026-07-21, From 2022-10-01
2022-09-30$2.10M-12.0%2025-04-03, From 2021-10-01
2021-09-30$2.39M-50.4%2024-02-15, From 2020-10-01
2020-09-30$4.81M-22.1%2023-04-19, From 2019-10-01
2019-09-30$6.18M+3.5%2022-10-13, From 2018-10-01
2018-09-30$5.97Mn/a2021-03-09, From 2017-10-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
BGM Group Ltd. (BGM)2025-09-30-$12.58Mn/m
Lftd Partners Inc. (LIFD)2025-12-31$913.2Kn/m
Sunshine Biopharma Inc. (SBFM)2025-12-31-$6.23Mn/m
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31-$12.19Mn/m
Bioharvest Sciences Inc. (BHST)2025-12-31-$5.58Mn/m
Biofrontera Inc. (BFRI)2025-12-31-$11.35Mn/m
Wave Life Sciences, Inc. (WVE)2025-12-31-$215.38Mn/m
Xilio Therapeutics, Inc. (XLO)2025-12-31-$41.98Mn/m
Integrated Biopharma Inc (INBP)2026-06-30-$2.71Mn/m

Compare BGM, LIFD, SBFM, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗